Protein nanoparticles as drug delivery carriers for cancer therapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lohcharoenkal, Warangkana ^a   Wang, Liying ^b   Chen, Yi Charlie ^c   Rojanasakul, Yon ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c Alderson Broaddus College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AVENIN; BOVINE SERUM ALBUMIN; CASEIN; CATIONIC BOVINE SERUM ALBUMIN; DOXORUBICIN; ELASTIN; GELATIN; GLIADIN; GLOBULAR PROTEIN; HUMAN SERUM ALBUMIN; MILK PROTEIN; NANOCARRIER; PACLITAXEL; PHOSPHATIDYLCHOLINE; PROTEIN DERIVATIVE; PROTEIN NANOPARTICLE; SORBITAN OLEATE; SOYBEAN PROTEIN; TROPOELASTIN; UNCLASSIFIED DRUG; ZEIN; DRUG CARRIER; NANOPARTICLE; POLYMER; PROTEIN;

AMINO ACID COMPOSITION; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER CHEMOTHERAPY; COACERVATION; CONFORMATIONAL TRANSITION; CONNECTIVE TISSUE; CROSS LINKING; ELECTROSPRAY; EMULSION; HYDROLYSIS; HYDROSTATIC PRESSURE; IONIC STRENGTH; ISOELECTRIC POINT; MOLECULAR WEIGHT; PH; PHASE SEPARATION; PROTEIN UNFOLDING; REVIEW; SOLUBILITY; SOLVENT EXTRACTION; SURFACE CHARGE; TRANSITION TEMPERATURE; VISCOSITY; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; NEOPLASMS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NEOPLASMS; POLYMERS; PROTEINS;

EID: 84897516128     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/180549     Document Type: Review

References (95)

1. Pathak Y., Recent developments in nanoparticulate drug delivery systems. Drug Delivery Nanoparticles Formulation and Characterization 2009 New York, NY, USA Informa Healthcare USA 1 7
2. Jahanshahi M., Zhang Z., Lyddiatt A., Subtractive chromatography for purification and recovery of nano-bioproducts. IEE Proceedings Nanobiotechnology 2005 152 3 121 126 2-s2.0-21544458037 10.1049/ip-nbt:20045004 (Pubitemid 40921154)
3. Soppimath K. S., Aminabhavi T. M., Kulkarni A. R., Rudzinski W. E., Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 2001 70 1-2 1 20 2-s2.0-0035966497 10.1016/S0168-3659(00) 00339-4 (Pubitemid 32144788)
4. Coester C., Nayyar P., Samuel J., In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation. European Journal of Pharmaceutics and Biopharmaceutics 2006 62 3 306 314 2-s2.0-33644826104 10.1016/j.ejpb.2005.09.009 (Pubitemid 43356580)
5. Verma R. K., Garg S., Current status of drug delivery technologies and future directions. Pharmaceutical Technology 2001 25 1 14
6. Moghimi S. M., Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anti-Cancer Agents in Medicinal Chemistry 2006 6 6 553 561 2-s2.0-33750738904 10.2174/ 187152006778699130
7. Langer R., Drug delivery and targeting. Nature 1998 392 6679 5 10 2-s2.0-0032580354 (Pubitemid 28215187)
8. Gref R., Minamitake Y., Peracchia M. T., Trubetskoy V., Torchilin V., Langer R., Biodegradable long-circulating polymeric nanospheres. Science 1994 263 5153 1600 1603 2-s2.0-23444444512 (Pubitemid 24128361)
9. Kreuter J., Kreuter J., Nanoparticles. Colloidal Drug Delivery Systems 1994 New York, NY, USA Marcel Dekker 219 342
10. Jahanshahi M., Babaei Z., Protein nanoparticle: a unique system as drug delivery vehicles. African Journal of Biotechnology 2008 7 25 4926 4934 2-s2.0-58649115800
11. Jahanshahi M., Re-design of downstream processing techniques for nanoparticulate bioproducts. Iranian Journal of Biotechnology 2004 2 1 12
12. Marty J. J., Oppenheim R. C., Speiser P., Nanoparticles-a new colloidal drug delivery system. Pharmaceutica Acta Helvetiae 1978 53 1 17 23 2-s2.0-0017910704
13. Weber C., Coester C., Kreuter J., Langer K., Desolvation process and surface characterisation of protein nanoparticles. International Journal of Pharmaceutics 2000 194 1 91 102 2-s2.0-0033992170 10.1016/S0378-5173(99)00370-1
14. Ezpeleta I., Irache J. M., Stainmesse S., Chabenat C., Gueguen J., Popineau Y., Orecchioni A., Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. International Journal of Pharmaceutics 1996 131 2 191 200 2-s2.0-0029863293 10.1016/0378-5173(95)04338-1
15. Peters T., Serum albumin. Advances in Protein Chemistry 1985 37 161 245 2-s2.0-0021782306 10.1016/S0065-3233(08)60065-0
16. Kratz F., Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release 2008 132 3 171 181 2-s2.0-56949084877
17. Kratz F., Fichtner I., Beyer U., Schumacher P., Roth T., Fiebig H. H., Unger C., Antitumor activity of acid labile transferrin and albumin doxorubicin conjugates in in vitro and in vivo human tumour xenograft model. European Journal of Cancer 1997 33 175 175
18. Sawicka J., Microencapsulation of cholecalciferol by coacervation. Pharmazie 1990 45 4 264 265 2-s2.0-0025282994 (Pubitemid 20175291)
19. Ziv O., Avtalion R. R., Margel S., Immunogenicity of bioactive magnetic nanoparticles: natural and acquired antibodies. Journal of Biomedical Materials Research A 2008 85 4 1011 1021 2-s2.0-44149090281 10.1002/jbm.a.31518 (Pubitemid 351717970)
20. Jahanshahi M., Sanati M. H., Hajizadeh S., Babaei Z., Gelatin nanoparticle fabrication and optimization of the particle size. Physica Status Solidi A: Applications and Materials Science 2008 205 12 2898 2902 2-s2.0-57349099421 10.1002/pssa.200824329
21. Jahanshahi M., Sanati M. H., Babaei Z., Optimization of parameters for the fabrication of gelatin nanoparticles by the Taguchi robust design method. Journal of Applied Statistics 2008 35 12 1345 1353 2-s2.0-54049089995 10.1080/02664760802382426
22. Babaei Z., Jahanshahi M., Sanati M. H., Fabrication and evaluation of gelatine nanoparticles for delivering of anti-cancer drug. International Journal of NanoScience and Nanotechnology 2008 4 23 29
23. Schwick H. G., Heide K., Immunochemistry and immunology of collagen and gelatin. Bibliotheca Haematologica 1969 33 111 125 2-s2.0-0014648097
24. Azarmi S., Huang Y., Chen H., McQuarrie S., Abrams D., Roa W., Finlay W. H., Miller G. G., Löbenberg R., Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. Journal of Pharmacy and Pharmaceutical Sciences 2006 9 1 124 132 2-s2.0-33645036467
25. Jameela S. R., Jayakrishnan A., Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials 1995 16 10 769 775 2-s2.0-0029329224 10.1016/0142-9612(95)99639-4
26. Levy M. C., Rambourg P., Levy J., Potron G., Microencapsulation. IV: cross-linked hemoglobin microcapsules. Journal of Pharmaceutical Sciences 1982 71 7 759 762 2-s2.0-0019986743 (Pubitemid 12020310)
27. Digenis G. A., Gold T. B., Shah V. P., Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. Journal of Pharmaceutical Sciences 1994 83 7 915 921 2-s2.0-0028364665 10.1002/jps. 2600830702 (Pubitemid 24228538)
28. Bruce A., Alexander J., Julian L., Martin R., Keith R., Peter W., Molecular Biology of the Cell 2002 4th New York, NY, USA Garland Science pp. 151-152
29. Toonkool P., Regan D. G., Kuchel P. W., Morris M. B., Weiss A. S., Thermodynamic and hydrodynamic properties of human tropoelastin: analytical ultracentrifuge and pulsed field-gradient spin-echo NMR studies. The Journal of Biological Chemistry 2001 276 30 28042 28050 2-s2.0-0035958855 10.1074/jbc.M103391200
30. Mackay J. A., Chilkoti A., Temperature sensitive peptides: engineering hyperthermia-directed therapeutics. International Journal of Hyperthermia 2008 24 6 483 495 2-s2.0-54449098052 10.1080/02656730802149570
31. Urry D. W., Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. Journal of Physical Chemistry B 1997 101 51 11007 11028 2-s2.0-0038388786 (Pubitemid 127627954)
32. Arangoa M. A., Ponchel G., Orecchioni A. M., Renedo M. J., Duchêne D., Irache J. M., Bioadhesive potential of gliadin nanoparticulate systems. European Journal of Pharmaceutical Sciences 2000 11 4 333 341 2-s2.0-0033805197 10.1016/S0928-0987(00)00121-4
33. Arangoa M. A., Campanero M. A., Renedo M. J., Ponchel G., Irache J. M., Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharmaceutical Research 2001 18 11 1521 1527 2-s2.0-0034747890 10.1023/A:1013018111829 (Pubitemid 33022406)
34. Mirshahi T., Irache J. M., Nicolas C., Mirshahi M., Faure J. P., Gueguen J., Hecquet C., Orecchioni A. M., Adaptive immune responses of legumin nanoparticles. Journal of Drug Targeting 2002 10 8 625 631 2-s2.0-0036970896 10.1080/1061186021000066237 (Pubitemid 36124363)
35. Shukla R., Cheryan M., Zein: the industrial protein from corn. Industrial Crops and Products 2001 13 3 171 192 2-s2.0-0034824517 10.1016/S0926-6690(00) 00064-9 (Pubitemid 32826511)
36. Podaralla S., Perumal O., Preparation of zein nanoparticles by pH controlled nanoprecipitation. Journal of Biomedical Nanotechnology 2010 6 4 312 317 2-s2.0-79953002227 10.1166/jbn.2010.1137
37. Dawson P. L., Hirt D. E., Rieck J. R., Acton J. C., Sotthibandhu A., Nisin release from films is affected by both protein type and film-forming method. Food Research International 2003 36 9-10 959 968 2-s2.0-10744230406 10.1016/S0963-9969(03)00116-9 (Pubitemid 37435414)
38. Hurtado-López P., Murdan S., Zein microspheres as drug/antigen carriers: a study of their degradation and erosion, in the presence and absence of enzymes. Journal of Microencapsulation 2006 23 3 303 314 2-s2.0-33744819762 10.1080/02652040500444149 (Pubitemid 43977082)
39. Riche M., Williams T. N., Apparent digestible protein, energy and amino acid availability of three plant proteins in Florida pompano, Trachinotus carolinus L. in seawater and low-salinity water. Aquaculture Nutrition 2010 16 3 223 230 2-s2.0-77953749184 10.1111/j.1365-2095.2009.00654.x
40. Teng Z., Liu C., Yang X., Li L., Tang C., Jiang Y., Fractionation of soybean globulins using Ca(2+) and Mg(2+): a comparative analysis. Journal of the American Oil Chemists' Society 2009 86 5 409 417 2-s2.0-67349218875 10.1007/s11746-009-1367-6
41. Li X., Li Y., Hua Y., Qiu A., Yang C., Cui S., Effect of concentration, ionic strength and freeze-drying on the heat-induced aggregation of soy proteins. Food Chemistry 2007 104 4 1410 1417 2-s2.0-34249026093 10.1016/j.foodchem.2007.02.003 (Pubitemid 46783262)
42. Liu D., Tian H., Zeng J., Chang P. R., Core-shell nanoblends from soy protein/ polystyrene by emulsion polymerization. Macromolecular Materials and Engineering 2008 293 8 714 721 2-s2.0-50249155430 10.1002/mame.200800119
43. Lazko J., Popineau Y., Legrand J., Soy glycinin microcapsules by simple coacervation method. Colloids and Surfaces B: Biointerfaces 2004 37 1-2 1 8 2-s2.0-4444289463 10.1016/j.colsurfb.2004.06.004 (Pubitemid 39164187)
44. Livney Y. D., Milk proteins as vehicles for bioactives. Current Opinion in Colloid and Interface Science 2010 15 1-2 73 83 2-s2.0-75849156917 10.1016/j.cocis.2009.11.002
45. Reddy I. M., Kella N. K. D., Kinsella J. E., Structural and conformational basis of the resistance of β -lactoglobulin to peptic and chymotryptic digestion. Journal of Agricultural and Food Chemistry 1988 36 4 737 741 2-s2.0-0000443256
46. Ko S., Gunasekaran S., Preparation of sub-100-nm β -lactoglobulin (BLG) nanoparticles. Journal of Microencapsulation 2006 23 8 887 898 2-s2.0-33847391136 10.1080/02652040601035143 (Pubitemid 46332100)
47. Fox P. E., McSweeney P. L. H., Advanced Dairy Chemistry 2003 3rd New York, NY, USA Kluwer Academic/Plenum
48. De Kruif C. G., Casein micelle interactions. International Dairy Journal 1999 9 3-6 183 188 2-s2.0-0032839313 10.1016/S0958-6946(99)00058-8 (Pubitemid 29395639)
49. McMahon D. J., Ommen B. S., Supramolecular structure of the casein micelle. Journal of Dairy Science 2008 91 5 1709 1721 2-s2.0-44349125136 (Pubitemid 351730874)
50. de Keuif C. G., Holl C., Caesin micelle structure, function and interactions. Advanced Dairy Chemistry: Proteins, Part A 2003 New York, NY, USA Kluwer Academic/Plenum 233 276
51. Abd El-Salam M. H., El-Shibiny S., Formation and potential uses of milk proteins as nano delivery vehicles for nutraceuticals: a review. International Journal of Dairy Technology 2012 65 1 13 21 2-s2.0-84855496627 10.1111/j.1471-0307.2011.00737.x
52. Qiu Y., Park K., Environment-sensitive hydrogels for drug delivery. Advanced Drug Delivery Reviews 2001 53 3 321 339 2-s2.0-0035981078 10.1016/S0169-409X(01)00203-4 (Pubitemid 34024913)
53. Wang Q., Allen J. C., Swaisgood H. E., Binding of retinol to beta-lactoglobulin isolated by bioselective adsorption. Journal of Dairy Science 1997 80 6 1047 1053 2-s2.0-0031160713 (Pubitemid 127447086)
54. Duclairoir C., Orecchioni A. M., Depraetere P., Nakache E., α -tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles. Journal of Microencapsulation 2002 19 1 53 60 2-s2.0-0036153497 10.1080/02652040110055207 (Pubitemid 34083462)
55. Langer K., Balthasar S., Vogel V., Dinauer N., von Briesen H., Schubert D., Optimization of the preparation process for human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics 2003 257 1-2 169 180 2-s2.0-0037433794 10.1016/S0378-5173(03)00134-0 (Pubitemid 36507043)
56. Wang G., Siggers K., Zhang S., Jiang H., Xu Z., Zernicke R. F., Matyas J., Uluda H., Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharmaceutical Research 2008 25 12 2896 2909 2-s2.0-57149125027 10.1007/s11095-008-9692-2
57. Kaul G., Amiji M., Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. Journal of Drug Targeting 2004 12 9-10 585 591 2-s2.0-11944266278 10.1080/10611860400013451 (Pubitemid 40100706)
58. Irache J. M., Bergougnoux L., Ezpeleta I., Gueguen J., Orecchioni A., Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method. International Journal of Pharmaceutics 1995 126 1-2 103 109 2-s2.0-0029616112 10.1016/0378-5173(95)04103-6 (Pubitemid 26015629)
59. Orecchioni A., Duclairoir C., Renard D., Nakache E., Gliadin characterization by sans and gliadin nanoparticle growth modelization. Journal of Nanoscience and Nanotechnology 2006 6 9-10 3171 3178 2-s2.0-33750037619 10.1166/jnn.2006.455 (Pubitemid 44579997)
60. Nahar M., Mishra D., Dubey V., Jain N. K., Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine 2008 4 3 252 261 2-s2.0-49649122787 10.1016/j.nano.2008.03.007
61. Langer K., Anhorn M. G., Steinhauser I., Dreis S., Celebi D., Schrickel N., Faust S., Vogel V., Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. International Journal of Pharmaceutics 2008 347 1-2 109 117 2-s2.0-36549054137 10.1016/j.ijpharm.2007.06.028 (Pubitemid 350180317)
62. Wang G., Uludag H., Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opinion on Drug Delivery 2008 5 5 499 515 2-s2.0-45849090317 10.1517/17425247.5.5.499 (Pubitemid 351877431)
63. Neradovic D., Soga O., van Nostrum C. F., Hennink W. E., The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N -isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials 2004 25 12 2409 2418 2-s2.0-0347760399 10.1016/j.biomaterials.2003.09.024 (Pubitemid 38102394)
64. Merodio M., Arnedo A., Renedo M. J., Irache J. M., Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. European Journal of Pharmaceutical Sciences 2000 12 3 251 259 2-s2.0-0033674934 10.1016/S0928-0987(00)00169-X
65. Yang L., Cui F., Cun D., Tao A., Shi K., Lin W., Preparation, characterization and biodistribution of the lactone form of 10- hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. International Journal of Pharmaceutics 2007 340 1-2 163 172 2-s2.0-34447254060 10.1016/j.ijpharm.2007.03.028 (Pubitemid 47043353)
66. Mishra V., Mahor S., Rawat A., Gupta P. N., Dubey P., Khatri K., Vyas S. P., Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. Journal of Drug Targeting 2006 14 1 45 53 2-s2.0-33645781775 10.1080/10611860600612953
67. Zhang W., Zhong Q., Microemulsions as nanoreactors to produce whey protein nanoparticles with enhanced heat stability by sequential enzymatic cross-linking and thermal pretreatments. Journal of Agricultural and Food Chemistry 2009 57 19 9181 9189 2-s2.0-70349895279 10.1021/jf902045u
68. Müller B. G., Leuenberger H., Kissel T., Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharmaceutical Research 1996 13 1 32 37 2-s2.0-0029867284 10.1023/A: 1016064930502 (Pubitemid 26076293)
69. Truong-Le V. L., August J. T., Leong K. W., Controlled gene delivery by DNA-gelatin nanospheres. Human Gene Therapy 1998 9 12 1709 1717 2-s2.0-17344362958 (Pubitemid 28418741)
70. Rhaese S., von Briesen H., Rübsamen-Waigmann H., Kreuter J., Langer K., Human serum albumin-polyethylenimine nanoparticles for gene delivery. Journal of Controlled Release 2003 92 1-2 199 208 2-s2.0-0141853247 10.1016/S0168-3659(03)00302-X (Pubitemid 37130132)
71. Mayer G., Vogel V., Weyermann J., Lochmann D., Van Den Broek J. A., Tziatzios C., Haase W., Wouters D., Schubert U. S., Zimmer A., Kreuter J., Schubert D., Oligonucleotide-protamine-albumin nanoparticles: protamine sulfate causes drastic size reduction. Journal of Controlled Release 2005 106 1-2 181 187 2-s2.0-23744445297 10.1016/j.jconrel.2005.04.019 (Pubitemid 41140093)
72. Zwiorek K., Kloeckner J., Wagner E., Coester C., Gelatin nanoparticles as a new and simple gene delivery system. Journal of Pharmacy and Pharmaceutical Sciences 2004 7 4 22 28 2-s2.0-22644441692 (Pubitemid 41522055)
73. Xu X., Capito R. M., Spector M., Delivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticles. Journal of Biomedical Materials Research A 2008 84 1 73 83 2-s2.0-36949005434 10.1002/jbm.a.31372 (Pubitemid 350244248)
74. Gulfam M., Kim J., Lee J. M., Ku B., Chung B. H., Chung B. G., Anticancer drug-loaded gliadin nanoparticles induced apoptosis in breast cancer cells. Langmuir 2012 28 8216 8223
75. Wu Y., Mackay J. A., Mcdaniel J. R., Chilkoti A., Clark R. L., Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying. Biomacromolecules 2009 10 1 19 24 2-s2.0-58549112215 10.1021/bm801033f
76. GLOBOCAN, Database (version 1. 2). 2008 http://globocan.iarc.fr
77. Zhang J., Lan C. Q., Post M., Simard B., Deslandes Y., Hsieh T. H., Design of nanoparticles as drug carriers for cancer therapy. Cancer Genomics and Proteomics 2006 3 3-4 147 158 2-s2.0-33746635660
78. Kommareddy S., Amiji M., Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine: Nanotechnology, Biology, and Medicine 2007 3 1 32 42 2-s2.0-33947263729 10.1016/j.nano.2006.11.005 (Pubitemid 46428185)
79. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D. A., Torchilin V. P., Jain R. K., Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Research 1995 55 17 3752 3756 2-s2.0-0029150245
80. Alexis F., Pridgen E. M., Langer R., Farokhzad O. C., Nanoparticle technologies for cancer therapy. Handbook of Experimental Pharmacology 2010 197 55 86 2-s2.0-77953235193 10.1007/978-3-642-00477-3-2
81. Chen L., Remondetto G. E., Subirade M., Food protein-based materials as nutraceutical delivery systems. Trends in Food Science and Technology 2006 17 5 272 283 2-s2.0-33646008554 10.1016/j.tifs.2005.12.011
82. Takakura Y., Fujita T., Hashida M., Sezaki H., Disposition characteristics of macromolecules in tumor-bearing mice. Pharmaceutical Research 1990 7 4 339 346 2-s2.0-0025148495 10.1023/A:1015807119753 (Pubitemid 20266586)
83. Gradishar W. J., Albumin-bound paclitaxel: a next-generation taxane. Expert Opinion on Pharmacotherapy 2006 7 8 1041 1053 2-s2.0-33745458519 10.1517/14656566.7.8.1041 (Pubitemid 43949942)
84. Hawkins M. J., Soon-Shiong P., Desai N., Protein nanoparticles as drug carriers in clinical medicine. Advanced Drug Delivery Reviews 2008 60 8 876 885 2-s2.0-42649132499 10.1016/j.addr.2007.08.044
85. Desai N., Trieu V., Yao Z., Louie L., Ci S., Yang A., Tao C., De T., Beals B., Dykes D., Noker P., Yao R., Labao E., Hawkins M., Soon-Shiong P., Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clinical Cancer Research 2006 12 4 1317 1324 2-s2.0-33644753906 10.1158/1078-0432.CCR-05-1634 (Pubitemid 43342524)
86. Nyman D. W., Campbell K. J., Hersh E., Long K., Richardson K., Trieu V., Desai N., Hawkins M. J., Von Hoff D. D., Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. Journal of Clinical Oncology 2005 23 31 7785 7793 2-s2.0-32944481043 10.1200/JCO.2004.00.6148 (Pubitemid 46657375)
87. Han J., Wang Q., Zhang Z., Gong T., Sun X., Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastasis cancer. Small 2013 10 3 524 535 10.1002/smll.201301992
88. Lee G. Y., Park K., Nam J. H., Kim S. Y., Byun Y., Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice. Journal of Drug Targeting 2006 14 10 707 716 2-s2.0-33845533182 10.1080/10611860600935701 (Pubitemid 44921529)
89. Aswathy R. G., Sivakumar B., Brahatheeswaran D., Fukuda T., Yoshida Y., Maekawa T., Kumar D. S., Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application. Advances in Natural Sciences: Nanoscience and Nanotechnology 2012 3 2 025006 10.1088/2043-6262/3/2/ 025006
90. Zhen X., Wang X., Xie C., Wu W., Jiang X., Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials 2013 34 1372 1382
91. Elzoghby A. O., Saad N. I., Helmy M. W., Samy W. M., Elgindy N. A., Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats. European Journal of Pharmaceutics and Biopharmaceutics 2013 85 3, part A 444 451
92. Schneider Y., Abarca J., Pirak A. E., Baurain R., Ceulemans F., Deprez-de Campaneere D., Lesur B., Masquelier M., Otte-Slachmuylder C., Rolin-van Swieten D., Trouet A., Drug targeting in human cancerchemotherapy. Receptor-Mediated Targeting of Drugs 1984 Springer 1 25 NATO ASI Series A: Life Sciences
93. Golla K., Bhaskar C., Ahmed F., Kondapi A. K., A target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hapatocellular cancer. Journal of Cancer 2013 4 644 652
94. Wartlick H., Michaelis K., Balthasar S., Strebhardt K., Kreuter J., Langer K., Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. Journal of Drug Targeting 2004 12 7 461 471 2-s2.0-9444221978 10.1080/10611860400010697 (Pubitemid 39562430)
95. Teng Z., Luo Y., Wang T., Zhang B., Wang Q., Development and application of nanoparticles synthesized with folic acid conjugated soy protein. Journal of Agricultural and Food Chemistry 2013 61 2556 2564